American Capital Advisory’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375 Sell
2
-3
-60% -$552 ﹤0.01% 998
2026
Q1
$944 Buy
5
+4
+400% +$843 ﹤0.01% 707
2025
Q4
$199 Hold
1
﹤0.01% 924
2025
Q3
$204 Buy
+1
New +$177 ﹤0.01% 872
2025
Q2
Sell
-1
Closed -$135 991
2025
Q1
$135 Buy
+1
New +$132 ﹤0.01% 773

Other funds holding THC

American Capital Advisory's THC Position: Q2 2026 in Review

American Capital Advisory reduced its Tenet Healthcare (THC) stake by 60% in Q2 2026, selling an estimated $552 and leaving 2 shares worth $375. The position accounts for ﹤0.01% of the portfolio, ranked #998.

American Capital Advisory first reported a position in THC in Q1 2025 and has held it in 5 quarters since. The position peaked at $944 in Q1 2026. 680 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • American Capital Advisory held 2 shares of Tenet Healthcare worth $375 as of Q2 2026.
  • American Capital Advisory sold 3 Tenet Healthcare shares in Q2 2026, an estimated $552.
  • Tenet Healthcare made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #998 holding.
  • American Capital Advisory first reported a position in Tenet Healthcare in Q1 2025 and has held it in 5 quarters since.
  • American Capital Advisory's Tenet Healthcare position peaked at $944 in Q1 2026.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.